Items where authors include "Moriceau, G."

Article

Gobin, B., Moriceau, G., Ory, B. et al. (5 more authors) (2014) Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models. PLoS ONE, 9 (3). e90795. ISSN 1932-6203

Moriceau, G., Roelofs, A.J., Brion, R. et al. (4 more authors) (2012) Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Cancer, 118 (3). pp. 750-760. ISSN 0008-543X

Moriceau, G., Ory, B., Mitrofan, L. et al. (11 more authors) (2010) Zoledronic Acid Potentiates mTOR Inhibition and Abolishes the Resistance of Osteosarcoma Cells to RAD001 (Everolimus): Pivotal Role of the Prenylation Process. Cancer Research, 70 (24). pp. 10329-10339. ISSN 0008-5472

Moriceau, G., Ory, B., Gobin, B. et al. (5 more authors) (2010) Therapeutic Approach of Primary Bone Tumours by Bisphosphonates. Current Pharmaceutical Design, 16 (27). pp. 2981-2987. ISSN 1381-6128

Ory, B., Moriceau, G., Redini, F. et al. (1 more author) (2007) mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: Bi-functional compounds for the treatment of bone tumours. Current Medicinal Chemistry, 14 (13). pp. 1381-1387. ISSN 0929-8673